- Home
- USCB vs HQL Comparison
USCB vs HQL Comparison
Compare USCB & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- HQL
- Stock Information
- Founded
- USCB 2002
- HQL 1992
- Country
- USCB United States
- HQL United States
- Employees
- USCB N/A
- HQL N/A
- Industry
- USCB Major Banks
- HQL Investment Managers
- Sector
- USCB Finance
- HQL Finance
- Exchange
- USCB Nasdaq
- HQL Nasdaq
- Market Cap
- USCB 366.2M
- HQL 368.7M
- IPO Year
- USCB 2021
- HQL N/A
- Fundamental
- Price
- USCB $18.63
- HQL $12.29
- Analyst Decision
- USCB Buy
- HQL
- Analyst Count
- USCB 2
- HQL 0
- Target Price
- USCB $18.25
- HQL N/A
- AVG Volume (30 Days)
- USCB 39.8K
- HQL 120.9K
- Earning Date
- USCB 04-24-2025
- HQL 01-01-0001
- Dividend Yield
- USCB 1.35%
- HQL 11.56%
- EPS Growth
- USCB 47.62
- HQL N/A
- EPS
- USCB 1.24
- HQL 0.79
- Revenue
- USCB $79,519,000.00
- HQL N/A
- Revenue This Year
- USCB $22.51
- HQL N/A
- Revenue Next Year
- USCB $7.69
- HQL N/A
- P/E Ratio
- USCB $14.97
- HQL $17.08
- Revenue Growth
- USCB 25.02
- HQL N/A
- 52 Week Low
- USCB $10.25
- HQL $11.34
- 52 Week High
- USCB $21.86
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- USCB 48.94
- HQL 26.87
- Support Level
- USCB $18.40
- HQL $12.90
- Resistance Level
- USCB $19.20
- HQL $13.30
- Average True Range (ATR)
- USCB 0.52
- HQL 0.23
- MACD
- USCB 0.02
- HQL -0.04
- Stochastic Oscillator
- USCB 47.72
- HQL 3.81
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.